Cadherin-6 is a putative tumor suppressor and target of epigenetically dysregulated miR-429 in cholangiocarcinoma. Issue 11 (1st November 2016)
- Record Type:
- Journal Article
- Title:
- Cadherin-6 is a putative tumor suppressor and target of epigenetically dysregulated miR-429 in cholangiocarcinoma. Issue 11 (1st November 2016)
- Main Title:
- Cadherin-6 is a putative tumor suppressor and target of epigenetically dysregulated miR-429 in cholangiocarcinoma
- Authors:
- Goeppert, Benjamin
Ernst, Christina
Baer, Constance
Roessler, Stephanie
Renner, Marcus
Mehrabi, Arianeb
Hafezi, Mohammadreza
Pathil, Anita
Warth, Arne
Stenzinger, Albrecht
Weichert, Wilko
Bähr, Marion
Will, Rainer
Schirmacher, Peter
Plass, Christoph
Weichenhan, Dieter - Abstract:
- ABSTRACT: Cholangiocarcinoma (CC) is a rare malignancy of the extrahepatic or intrahepatic biliary tract with an outstanding poor prognosis. Non-surgical therapeutic regimens result in minimally improved survival of CC patients. Global genomic analyses identified a few recurrently mutated genes, some of them in genes involved in epigenetic patterning. In a previous study, we demonstrated global DNA methylation changes in CC, indicating major contribution of epigenetic alterations to cholangiocarcinogenesis. Here, we aimed at the identification and characterization of CC-related, differentially methylated regions (DMRs) in potential microRNA promoters and of genes targeted by identified microRNAs. Twenty-seven hypermethylated and 13 hypomethylated potential promoter regions of microRNAs, known to be associated with cancer-related pathways like Wnt, ErbB, and PI3K-Akt signaling, were identified. Selected DMRs were confirmed in 2 independent patient cohorts. Inverse correlation between promoter methylation and expression suggested miR-129-2 and members of the miR-200 family (miR-200a, miR-200b, and miR-429) as novel tumor suppressors and oncomiRs, respectively, in CC. Tumor suppressor genes deleted in liver cancer 1 ( DLC1 ), F-box/WD-repeat-containing protein 7 ( FBXW7 ), and cadherin-6 ( CDH6 ) were identified as presumed targets in CC. Tissue microarrays of a representative and well-characterized cohort of biliary tract cancers (n=212) displayed stepwise downregulation ofABSTRACT: Cholangiocarcinoma (CC) is a rare malignancy of the extrahepatic or intrahepatic biliary tract with an outstanding poor prognosis. Non-surgical therapeutic regimens result in minimally improved survival of CC patients. Global genomic analyses identified a few recurrently mutated genes, some of them in genes involved in epigenetic patterning. In a previous study, we demonstrated global DNA methylation changes in CC, indicating major contribution of epigenetic alterations to cholangiocarcinogenesis. Here, we aimed at the identification and characterization of CC-related, differentially methylated regions (DMRs) in potential microRNA promoters and of genes targeted by identified microRNAs. Twenty-seven hypermethylated and 13 hypomethylated potential promoter regions of microRNAs, known to be associated with cancer-related pathways like Wnt, ErbB, and PI3K-Akt signaling, were identified. Selected DMRs were confirmed in 2 independent patient cohorts. Inverse correlation between promoter methylation and expression suggested miR-129-2 and members of the miR-200 family (miR-200a, miR-200b, and miR-429) as novel tumor suppressors and oncomiRs, respectively, in CC. Tumor suppressor genes deleted in liver cancer 1 ( DLC1 ), F-box/WD-repeat-containing protein 7 ( FBXW7 ), and cadherin-6 ( CDH6 ) were identified as presumed targets in CC. Tissue microarrays of a representative and well-characterized cohort of biliary tract cancers (n=212) displayed stepwise downregulation of CDH6 and association with poor patient outcome. Ectopic expression of CDH6 on the other hand, delayed growth in the CC cell lines EGI-1 and TFK-1, together suggesting a tumor suppressive function of CDH6 . Our work represents a valuable repository for the study of epigenetically altered miRNAs in cholangiocarcinogenesis and novel putative, CC-related tumor suppressive miRNAs and oncomiRs. … (more)
- Is Part Of:
- Epigenetics. Volume 11:Issue 11(2016)
- Journal:
- Epigenetics
- Issue:
- Volume 11:Issue 11(2016)
- Issue Display:
- Volume 11, Issue 11 (2016)
- Year:
- 2016
- Volume:
- 11
- Issue:
- 11
- Issue Sort Value:
- 2016-0011-0011-0000
- Page Start:
- 780
- Page End:
- 790
- Publication Date:
- 2016-11-01
- Subjects:
- Biliary tract cancer -- DNA methylation -- epigenomics -- microRNA -- patient survival
Epigenesis -- Periodicals
Epigenetica
572.86505 - Journal URLs:
- http://www.landesbioscience.com/journals/epigenetics/ ↗
http://www.tandfonline.com/toc/kepi20/current ↗
http://www.tandfonline.com/ ↗ - DOI:
- 10.1080/15592294.2016.1227899 ↗
- Languages:
- English
- ISSNs:
- 1559-2294
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3793.650300
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 2458.xml